PharmacyCodes



Dihydroergotaminum [INN-Latin] en es it fr

Dihydroergotaminum [INN-Latin] Brand names, Dihydroergotaminum [INN-Latin] Analogs

Dihydroergotaminum [INN-Latin] Brand Names Mixture

  • No information avaliable

Dihydroergotaminum [INN-Latin] Chemical_Formula

C33H37N5O5

Dihydroergotaminum [INN-Latin] RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Dihydroergotaminum [INN-Latin] fda sheet

Dihydroergotaminum_[INN-Latin] FDA

Dihydroergotaminum [INN-Latin] msds (material safety sheet)

Dihydroergotaminum_[INN-Latin] MSDS

Dihydroergotaminum [INN-Latin] Synthesis Reference

No information avaliable

Dihydroergotaminum [INN-Latin] Molecular Weight

583.678 g/mol

Dihydroergotaminum [INN-Latin] Melting Point

No information avaliable

Dihydroergotaminum [INN-Latin] H2O Solubility

No information avaliable

Dihydroergotaminum [INN-Latin] State

Solid

Dihydroergotaminum [INN-Latin] LogP

No information avaliable

Dihydroergotaminum [INN-Latin] Dosage Forms

Liquid

Dihydroergotaminum [INN-Latin] Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Dihydroergotaminum [INN-Latin] Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Dihydroergotaminum [INN-Latin] Absorption

Interpatient variable and may be dependent on the administration technique

Dihydroergotaminum [INN-Latin] side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Dihydroergotaminum [INN-Latin] Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Dihydroergotaminum [INN-Latin] Organisms Affected

Humans and other mammals